Stayble Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:4K4 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Jun 24	Buy€4,296	Andreas Gerward	Individual	160,000	€0.027
12 Jun 24	Buy€917	Thomas Palsson	Individual	32,000	€0.029
08 Dec 23	Buy€1,234	Thomas Palsson	Individual	50,000	€0.025

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 37.8%.

Top 12 shareholders own 28.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.68%	Chalmers Tekniska Högskola, Endowment Arm	3,355,940	€153.2k	0%	83.06%
4.43%	Almi Invest AB	1,935,584	€88.4k	0%	6.95%
4%	Nordnet AB (publ), Asset Management Arm	1,748,371	€79.8k	0%	0.01%
3.97%	Avanza Fonder AB	1,736,388	€79.3k	0%	no data
2.58%	Robert Joki	1,127,804	€51.5k	0%	no data
1.36%	Futur Pension Försäkringsaktiebolag, Asset Management Arm	595,000	€27.2k	0%	0.01%
1.19%	Andreas Gerward	520,000	€23.7k	0%	no data
1.16%	Ålandsbanken Asset Management Ab	505,200	€23.1k	0%	0.03%
1.14%	Kjell Olmarker	500,000	€22.8k	0%	no data
1.04%	Handelsbanken Asset Management	456,025	€20.8k	0%	no data
0.32%	Thomas Palsson	138,000	€6.3k	0%	no data
0.0064%	FCG Fonder AB	2,804	€127.9	0%	no data